Ginseng-Derived Compounds · Integrative Oncology

Careseng and Cancer: Ginsenoside Research, Safety and Integrative Use

Careseng is described as a concentrated ginseng-derived preparation associated with protopanaxadiol-type compounds, including ginsenosides studied in cancer biology. Laboratory research is scientifically interesting, but product-specific human cancer evidence remains limited.

At Sunridge Medical, a ginseng-derived product may be considered only after the cancer diagnosis, current treatment, medicines, blood sugar, blood pressure, bleeding risk and the patient’s goals are reviewed. It is not presented as a replacement for proven cancer treatment.

Evidence clearly labeledInteraction review requiredPhysician-directed use

Request an Integrative Review →Call 1-800-923-7878

Panax ginseng root, extract vials and molecular model in a laboratory studying ginsenosides and cancer biology — Ginseng contains many compounds; research on isolated ginsenosides cannot automatically be applied to every commercial ginseng product.

Ginsenoside consultation

Personalize a Ginsenoside Strategy Around the Actual Product

Ginseng preparations are not interchangeable. A physician can review the product, standardized constituents, medications, treatment schedule and the supportive-care goal.

Product identity and dose are confirmed first
Bleeding, glucose and medication considerations are reviewed
Call now for an immediate response from our Patient Care Team

Call 1-800-923-7878 →

Ginsenoside consultation

Speak With Our Patient Care Team

Share the exact ginseng or ginsenoside product, dose and current cancer treatment.

* Required fields

Prefer to speak with someone now?

1-800-923-7878

Product identity and dose are confirmed first
Bleeding, glucose and medication considerations are reviewed
Questions before scheduling are always welcome

Careseng · Quick Answers

What Patients Should Know Before Considering a Ginseng-Derived Product

What it is

A Concentrated Botanical Preparation

Careseng has been described in early literature as a ginseng-derived product containing protopanaxadiol-related compounds. Exact composition, standardization and availability should be verified for the product actually used.

Cancer evidence

Mostly Laboratory and Animal Research

Ginsenoside Rh2 and related compounds have shown effects on apoptosis, proliferation, metabolism, invasion and drug-resistance pathways in preclinical models. These findings do not prove tumor control in people.

Human evidence

Better Evidence Exists for Fatigue

Randomized trials of American ginseng—not Careseng—suggest a possible benefit for cancer-related fatigue. Different species, extracts and doses are not interchangeable.

Safety

Natural Does Not Mean Interaction-Free

Ginseng may affect sleep, blood sugar, blood pressure, clotting and medicines. The exact formulation and complete treatment list should be reviewed before use.

Understand the Product

Careseng, Ginseng and Ginsenosides Are Related—but Not Identical

“Ginseng” can refer to several Panax species, including Asian ginseng (Panax ginseng) and American ginseng (Panax quinquefolius). Their chemical profiles differ. Processing methods such as steaming, fermentation and extraction can also change which ginsenosides are present and how concentrated they are.

Ginsenosides are steroid-like saponins found in Panax plants. Rh2, compound K and protopanaxadiol metabolites are among the compounds studied in cancer models. Careseng has historically been described as a natural ginseng product associated with aglycone protopanaxadiol. A study of one isolated compound does not establish the activity of a different root powder, extract or proprietary blend.

The label must match the evidence

Before discussing use, verify: botanical species, plant part, extraction method, active-compound standardization, dose, contaminant testing, expiration, manufacturer and whether the exact formulation has published human data.

Why Researchers Are Interested

Ginsenosides Affect Multiple Cancer-Related Pathways in Preclinical Models

Laboratory research on ginsenoside Rh2 and related compounds has examined programmed cell death, cell-cycle regulation, oxidative stress, NF-κB, PI3K/AKT/mTOR, mitochondrial metabolism, angiogenesis, invasion and immune signaling. Some studies also investigate P-glycoprotein, a transporter that can contribute to multidrug resistance.

Apoptosis

Cell-Death Signaling

Rh2 has induced apoptosis or autophagy in multiple cancer cell lines through pathways involving caspases, BCL-2 family proteins, p53 and mitochondrial signaling.

Metabolism

Mitochondrial Reprogramming

Recent non-small-cell lung-cancer research linked Rh2 with HIF-1α/PDK4 signaling, oxidative phosphorylation and reactive oxygen species in experimental models.

Drug resistance

P-Glycoprotein Research

Early cell-line work reported that protopanaxadiol-related compounds could influence P-glycoprotein function. A cell-line result is not a clinical instruction to combine a supplement with chemotherapy.

Immune biology

Combination Hypotheses

Preclinical studies explore combinations with chemotherapy or immunotherapy. Benefits, harms, timing and dose must be established in well-designed human trials.

Important distinction: concentrations that affect isolated cancer cells may not be achievable or safe in the human body. Laboratory synergy does not guarantee clinical synergy.

What Human Research Shows

Clinical Evidence Is Stronger for Supportive Care Than for Treating Tumors

There is no high-quality evidence that Careseng alone shrinks tumors, prolongs survival or cures cancer. Early product-specific publications and conference abstracts are not substitutes for randomized controlled trials, and conflicts of interest, small samples and combined interventions must be considered.

Human research on other standardized ginseng preparations is more informative for symptom support. In a multicenter randomized trial, 364 people with cancer-related fatigue received American ginseng or placebo. The primary four-week comparison was not statistically significant, but fatigue improvement favored ginseng at eight weeks without a clear increase in measured toxicities. This trial used a specific American ginseng preparation at a defined dose; it did not test Careseng or establish anticancer activity.

Systematic reviews report small or inconsistent improvements in fatigue and some quality-of-life measures, with limitations from differences in ginseng species, formulations, trial quality and outcome measures.

A hopeful but accurate conclusion

Ginseng-derived compounds are biologically active and worthy of further study. At present, their most defensible clinical role is a carefully selected supportive or investigational strategy—not a stand-alone cancer treatment.

Safety and Interactions

Review Ginseng Like a Pharmacologically Active Treatment

Cancer patient and family member reviewing ginseng supplement safety and medication interactions with a physician — The safest integrative plan starts with the exact product and a complete medication, supplement and treatment list.

Reported ginseng effects include insomnia, headache, digestive symptoms, appetite change, fast heart rate, blood-pressure changes and changes in blood sugar. Rare allergic or liver reactions have been reported. Product contamination or substitution is another concern with poorly controlled supplements.

Review anticoagulants, antiplatelet medicines and bleeding risk
Monitor glucose when using insulin or diabetes medicines
Discuss blood-pressure, heart-rhythm and stimulant concerns
Review antidepressants, immunosuppressants and chemotherapy
Pause before surgery or procedures when the treating team advises
Avoid use in pregnancy unless a qualified clinician specifically approves it

Do not assume an interaction is helpful. Inhibiting a drug transporter could raise or lower exposure to medicines and toxicity. Oncology and pharmacy review is essential before combining concentrated ginseng compounds with treatment.

Physician-Directed Integrative Oncology

How Sunridge Evaluates a Ginseng-Derived Strategy

Sunridge begins with the cancer type, stage, pathology, biomarkers, treatment history, current plan, organ function, symptoms and goals. The team then reviews whether a botanical strategy has a specific purpose—such as fatigue support or a defined investigational rationale—and whether that purpose can be measured.

Before Starting

Confirm the exact product and standardized ingredients
Review medicines, supplements and infusion therapies
Check glucose, blood pressure, blood counts and organ function when relevant
Discuss the evidence level and realistic treatment goal
Coordinate with oncology when active treatment is underway

While Using It

Document dose, schedule and treatment timing
Track symptoms and the outcome being targeted
Monitor for sleep, glucose, bleeding or blood-pressure changes
Stop or adjust when toxicity, interaction or no meaningful benefit is seen
Never delay effective cancer therapy without an informed medical discussion

Ginseng-derived strategies may fit some integrative plans and be inappropriate in others. The decision should be individualized rather than based on the word “natural.”

Questions to Bring to a Consultation

Make the Decision Specific, Measurable and Safe

Is this Careseng, a standardized ginseng extract or an isolated ginsenoside?
What human evidence supports the goal being proposed?
Is the goal fatigue support, treatment tolerance or an experimental anticancer effect?
Could the product alter my chemotherapy, immunotherapy or anticoagulant exposure?
How will blood sugar, blood pressure, liver function and bleeding risk be monitored?
What result would count as benefit, and when will we reassess?
What would make us stop immediately?

Request a Treatment Review →Speak With Patient Care

Frequently Asked Questions

Careseng, Ginseng and Cancer Questions

What is Careseng?

Careseng has been described as a concentrated ginseng-derived preparation associated with protopanaxadiol-type compounds. Because formulations and availability may change, the exact current product and standardization must be verified.

Is Careseng the same as American ginseng?

No. American ginseng, Asian ginseng, red ginseng, isolated Rh2 and proprietary extracts can differ substantially. Evidence from one preparation should not automatically be applied to another.

Does Careseng kill cancer cells?

Ginsenoside and protopanaxadiol compounds have affected cancer cells in laboratory models. There is not high-quality human evidence proving that Careseng controls or cures cancer.

Can ginseng help cancer-related fatigue?

A randomized trial of a specific American ginseng preparation found a fatigue benefit at eight weeks. Results do not establish that every ginseng product works or that ginseng treats the cancer itself.

Can Careseng be combined with chemotherapy?

Only after oncology and pharmacy review. Preclinical combination findings are not dosing guidance, and effects on drug transporters, bleeding, glucose or organ function could create risk.

Can ginseng interfere with immunotherapy?

Reliable human interaction data are limited. Because ginseng compounds can affect immune signaling in experimental systems, use should be discussed with the treating oncologist rather than assumed safe.

What side effects can ginseng cause?

Insomnia is commonly reported. Headache, digestive symptoms, appetite change, heart-rate, blood-pressure or blood-sugar effects may occur. Rare allergic or liver reactions have also been reported.

Does the FDA approve ginseng as a cancer treatment?

No. The National Cancer Institute notes that the FDA has not approved ginseng to treat cancer or any other medical condition.

How does Sunridge decide whether to use it?

The physician reviews the exact formulation, goal, cancer treatment, medicines, organ function, symptoms and interaction risks. Any use is individualized and monitored.

Can I use a store-bought ginseng supplement instead?

Do not substitute products without review. Species, processing, dose, contaminants and active-compound levels can differ, so a store product may not match the evidence or the intended plan.

Primary Sources & Evidence Reviews

References

This page is educational and does not establish that Careseng or ginseng treats cancer. Product composition, regulation and availability can change. Decisions should be made with qualified oncology and integrative clinicians.

Considering a Ginseng-Derived Strategy?

Start With the Exact Product, the Evidence and Your Complete Treatment Plan.

Our Patient Care Team can explain which records and medication lists to send for a physician-directed integrative cancer consultation. We welcome questions from patients in active treatment, after treatment, at recurrence and with Stage 4 disease.

Request a Cancer Consultation →Call 1-800-923-7878

Living research library · positive published findings

Research organized by cancer type

Browse 35 source-linked studies with the full title, publication year, research focus and a concise finding. Select any linked cancer type to move directly to its corresponding Sunridge page.

Search the library

Cancer type

Brain cancer

Ginsenoside Rg5 inhibits glioblastoma by activating ferroptosis via NR3C1/HSPB1/NCOA4.

2024 · Metastasis and invasion

We aim to study whether ginsenoside Rg5 exerted inhibitory effects on crucial aspects of glioma stem cells, including cell viability, tumor initiation, invasion, self-renewal ability, neurosphere formation, and stemness.

Find the right place to begin

Conditions & Care

Treatments & Therapies

Plan Your Care

Cancer care that happens here

Start Here

Cancers We Treat

Treatment & Planning

Find the right place to begin

Conditions & Care

Treatments & Therapies

Plan Your Care

Cancer care that happens here

Start Here

Cancers We Treat

Treatment & Planning

Careseng and Cancer: Ginsenoside Research, Safety and Integrative Use

Personalize a Ginsenoside Strategy Around the Actual Product

Speak With Our Patient Care Team

What Patients Should Know Before Considering a Ginseng-Derived Product

A Concentrated Botanical Preparation

Mostly Laboratory and Animal Research

Better Evidence Exists for Fatigue

Natural Does Not Mean Interaction-Free

Careseng, Ginseng and Ginsenosides Are Related—but Not Identical

The label must match the evidence

Ginsenosides Affect Multiple Cancer-Related Pathways in Preclinical Models

Cell-Death Signaling

Mitochondrial Reprogramming

P-Glycoprotein Research

Combination Hypotheses

Clinical Evidence Is Stronger for Supportive Care Than for Treating Tumors

A hopeful but accurate conclusion

Review Ginseng Like a Pharmacologically Active Treatment

How Sunridge Evaluates a Ginseng-Derived Strategy

Before Starting

While Using It

Make the Decision Specific, Measurable and Safe

Careseng, Ginseng and Cancer Questions

References

Start With the Exact Product, the Evidence and Your Complete Treatment Plan.

Research organized by cancer type

Ginsenoside Rg5 inhibits glioblastoma by activating ferroptosis via NR3C1/HSPB1/NCOA4.

Fabrication of Ginsenoside-Based Nanodrugs for Enhanced Antitumor Efficacy on Triple-Negative Breast Cancer.

Ginsenoside CK induces apoptosis in triple-negative breast cancer cells by targeting glutamine metabolism.

Ginsenoside Rh2 inhibits breast cancer cell growth via ERβ-TNFα pathway.

Ginsenoside Rh2 regulates triple-negative breast cancer proliferation and apoptosis via the IL-6/JAK2/STAT3 pathway.

Ginseng Glucosyl Oleanolate Suppresses Cervical Cancer via Simultaneous Inhibition of Glycolysis and Oxidative Phosphorylation In Vivo/Vitro.

Ginsenoside (20)S-APPT induces ferroptosis in hepatocellular carcinoma and cholangiocarcinoma by targeting FSP1.

Possible role of ginseng as an additional therapy for cholangiocarcinoma therapy: A discussion on the role of vimentin suppression.

Ginsenoside Rh1 inhibits tumor growth in mice with colorectal cancer and depressive symptoms via modulation of the gut microbiota and tumor microenvironment.

Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism.

Rosmarinic acid in combination with ginsenoside Rg1 suppresses colon cancer metastasis via co-inhition of COX-2 and PD1/PD-L1 signaling axis.

20(S)-ginsenoside Rg3 suppresses gastric cancer cell proliferation by inhibiting E2F-DP dimerization.

Ginsenoside Rb1 carbon nanodots: A green and promising nanomedicine for effective gastric cancer treatment.

20(S)-Ginsenoside Rh2 Suppresses Oral Cancer Cell Growth by Inhibiting the Src-Raf-ERK Signaling Pathway.

Ginsenoside M1 Induces Apoptosis and Inhibits the Migration of Human Oral Cancer Cells.

Ginsenoside Rd inhibits migration and invasion of tongue cancer cells through H19/miR-675-5p/CDH1 axis.

Ginsenoside Rg3 Inhibits Migration and Invasion of Nasopharyngeal Carcinoma Cells and Suppresses Epithelial Mesenchymal Transition.

Ginsenoside 24-OH-PD from red ginseng inhibits acute T-lymphocytic leukaemia by activating the mitochondrial pathway.

Ginsenoside Rh2 and luteolin synergistically induce cellular senescence to suppress hepatocellular carcinoma progression through oxidative stress-mediated mechanisms.

Ginsenoside Rh3 enhances regorafenib efficacy in hepatocellular carcinoma by modulating FGFR4-STAT3-YAP signaling pathway.

Ginsenoside Rh4 inhibits inflammation-related hepatocellular carcinoma progression by targeting HDAC4/IL-6/STAT3 signaling.

Ginsenoside Rk1 induces autophagy-dependent apoptosis in hepatocellular carcinoma by AMPK/mTOR signaling pathway.

Ginsenoside RK1 Induces Ferroptosis in Hepatocellular Carcinoma Cells through an FSP1-Dependent Pathway.

Nanoparticle conjugation of ginsenoside Rh2 enhanced antitumor efficacy on hepatocellular carcinoma.

Compound K-enriched Korean red ginseng prevents lung cancer progression by targeting cancer cells and fibroblasts.

Ginsenoside Rh2 as a novel PIN1 inhibitor disrupting the cancer stem cell-like phenotype in non-small cell lung cancer.

Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer.

Particulate matter-induced lung cancer metastasis is inhibited by ginsenoside Rg3.

Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth.

Ginsenoside Re inhibits melanogenesis and melanoma growth by downregulating microphthalmia-associated transcription factor.

Ginsenoside Rg3 inhibits melanoma progression by inducing ferroptosis via the p53/SLC7A11/GPX4 pathway.

Ginsenoside 20(S)-Rg3 upregulates SQLE to reprogram cholesterol metabolism of ovarian cancer cells.

Ginsenoside Rh2 repressed the progression of prostate cancer through the mitochondrial damage induced by mitophagy and ferroptosis.

Induction of apoptosis in prostate cancer by ginsenoside Rh2.

Ginsenoside Rh2 inhibits thyroid cancer cell migration and proliferation via activation of miR-524-5p.

Explore Care

Services & Shop

Stay Connected